Literature DB >> 6861861

Effect of zopiclone on the arousal level of healthy volunteers assessed by the averaged photopalpebral reflex.

M Tanaka, Y Mizuki, H Isozaki, K Inanaga.   

Abstract

The averaged photopalpebral reflex (PPR) represents the mean of summed reflex contractions of the orbicularis oculi muscle in response to periodic photic stimuli. The latency of PPR can be used to assess a drug effect on human arousal level, since it is prolonged if there is a reduction in the arousal level of the subject. In the present study of the clinical effects of zopiclone, healthy male volunteers aged 18-22 years were given zopiclone 5 mg and 10 mg, nitrazepam 5 mg and 10 mg, or placebo, in a double-blind, cross-over design. Changes in the latencies of PPR were examined from 0.5 to 4 h after medication. Both zopiclone and nitrazepam prolonged the latency in a dose-dependent manner, but the prolongation induced by zopiclone appeared more rapidly, was slightly more marked and lasted for a shorter period than that induced by nitrazepam. Zopiclone produced slightly fewer subjective changes, such as vagueness of thought and weakness, than did nitrazepam. From these results, it is suggested that zopiclone possesses a potent hypnotic action which appears more rapidly and is slightly more potent and shorter lasting than that of nitrazepam. In addition, zopiclone may also exhibit fewer side effects, such as vagueness of thought and weakness than nitrazepam, and it may cause less "hang over".

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861861     DOI: 10.1007/bf00609888

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  The effects of a new benzodiazepine derivative, ID-540, on the averaged photopalpebral reflex in man.

Authors:  M Tanaka; H Isozaki; K Inanaga; N Ogawa
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

2.  Effects of ID-540 on averaged photopalpebral reflex in man.

Authors:  M Tanaka; H Isozaki; K Inanaga
Journal:  Jpn J Pharmacol       Date:  1977-08

3.  In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors.

Authors:  J C Blanchard; A Boireau; C Garret; L Julou
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

4.  Further studies of the anti-recall effect of lorazepam: A dose--time--effect relationship.

Authors:  S K Pandit; D V Heisterkamp; P J Cohen
Journal:  Anesthesiology       Date:  1976-11       Impact factor: 7.892

5.  [Treatment of sleep disorders with zopiclone. Clinical trials using a double-blind method versus placebo].

Authors:  R Duriez; C Barthelemy; H Rives; J Courjaret; J Gregoire
Journal:  Therapie       Date:  1979 May-Jun       Impact factor: 2.070

6.  Periodic appearance of theta rhythm in the frontal midline area during performance of a mental task.

Authors:  Y Mizuki; M Tanaka; H Isozaki; H Nishijima; K Inanaga
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-08

7.  A useful, physiological tool for assessing the arousal level in humans: averaged photopalpebral reflex.

Authors:  M Tanaka; Y Mizuki; H Isozaki; K Inanaga
Journal:  Folia Psychiatr Neurol Jpn       Date:  1983

8.  Comparative study of zopiclone, a novel hypnotic, and three benzodiazepines.

Authors:  E Wickstrøm; K E Giercksky
Journal:  Eur J Clin Pharmacol       Date:  1980-02       Impact factor: 2.953

  8 in total
  1 in total

Review 1.  Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.

Authors:  K L Goa; R C Heel
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.